Advertisement
U.S. markets open in 3 hours 19 minutes

  • S&P Futures

    4,587.75
    +12.75 (+0.28%)
     

  • Dow Futures

    36,245.00
    +56.00 (+0.15%)
     

  • Nasdaq Futures

    15,970.50
    +61.75 (+0.39%)
     

  • Russell 2000 Futures

    1,867.50
    +7.70 (+0.41%)
     

  • Crude Oil

    71.81
    -0.51 (-0.71%)
     

  • Gold

    2,040.10
    +3.80 (+0.19%)
     

  • Silver

    24.47
    -0.08 (-0.31%)
     

  • EUR/USD

    1.0790
    -0.0013 (-0.12%)
     

  • 10-Yr Bond

    4.1710
    0.0000 (0.00%)
     

  • Vix

    12.78
    -0.07 (-0.54%)
     

  • GBP/USD

    1.2593
    +0.0000 (+0.00%)
     

  • USD/JPY

    147.3950
    +0.2870 (+0.20%)
     

  • Bitcoin USD

    43,970.70
    +2,308.21 (+5.54%)
     

  • CMC Crypto 200

    896.87
    +36.33 (+4.22%)
     

  • FTSE 100

    7,518.33
    +28.49 (+0.38%)
     

  • Nikkei 225

    33,445.90
    +670.08 (+2.04%)
     

EU says Moderna COVID vaccine production can continue after contamination incident

1
Reuters
·1 min read

BRUSSELS, Aug 27 (Reuters) - Production of Moderna COVID-19 vaccines at a plant of partner Rovi in Spain can continue after an initial assessment, the European Union drugs regulator said on Friday, as it continues its investigation of a contamination incident.

On Thursday Japan suspended the use of 1.63 million doses of the Moderna vaccine, with the company saying contamination could be due to a manufacturing issue on one of the production lines at its contract manufacturing site in Spain run by Rovi .

"COVID-19 vaccine production in Rovi is able to continue, following a preliminary risk assessment of the information received so far," the European Medicines Agency told Reuters in a statement on Friday.

"An investigation into the root cause is ongoing. EMA will be able to provide more information as the investigation progresses," it added. (Reporting by Francesco Guarascio @fraguarascio; Editing by Catherine Evans)

Advertisement